Park Medi World reallocates Rs 648.32 million IPO proceeds for The Medicity Hospital acquisition, confirms CRISIL monitoring report
Monitoring Agency Report for Q2 FY2026 reveals approved fund reallocation and utilization status of IPO net proceeds of Rs 7,132.77 million
Park Medi World Limited disclosed the Monitoring Agency Report by CRISIL Ratings for the quarter ended September 30, 2026, detailing that IPO proceeds were utilized with a deviation approved by shareholders, including Rs 648.32 million reallocated for capital expenditure on The Medicity Hospital, Rudrapur acquisition.
Park Medi World Limited
General / Other
Park Medi World Limited announced that, as per the Monitoring Agency Report by CRISIL Ratings for the quarter ended September 30, 2026, the company utilized IPO proceeds with certain deviations from the original objects approved by shareholders. A key reallocation involved Rs 648.32 million directed towards funding capital expenditure for the acquisition of The Medicity Hospital, Rudrapur.
The report, submitted pursuant to SEBI regulations, confirms that while there was a deviation in fund usage from the Prospectus objectives, this was in accordance with shareholder-approved reallocations.
The IPO gross proceeds were Rs 7,700 million, with net proceeds after expenses amounting to Rs 7,132.77 million. The company reallocated Rs 648.32 million from specific objects outlined in the Offer Document to fund capital expenditure for the acquisition of The Medicity Hospital, Rudrapur.
Other monitored objects include repayment of borrowings, development of a new hospital, purchase of medical equipment, and unidentified inorganic acquisitions and general corporate purposes.
The reallocation deviation was within a 10% range, as noted in the report dated November 13, 2026, which is available on the company website.
Highlights
- IPO gross proceeds of Rs 7,700 million with net proceeds of Rs 7,132.77 million after issue expenses.
- Rs 648.32 million reallocated from original IPO objects to capital expenditure on acquisition of The Medicity Hospital, Rudrapur.
- Use of proceeds and deviations are compliant with shareholder approvals.
- Monitoring Agency Report issued by CRISIL Ratings for quarter ended September 30, 2026.
- Deviation in utilization is within 10% range as per monitoring norms.
Key Data Snapshot
What happened
- Park Medi World Limited disclosed the Monitoring Agency Report issued by CRISIL Ratings for the quarter ended September 30, 2026, regarding the utilization of IPO proceeds.
- The report identified deviations from the original objects in the Prospectus, authorized by shareholder approval for fund reallocation.
- A significant reallocation of Rs 648.32 million was made to fund capital expenditure concerning the acquisition of The Medicity Hospital, Rudrapur.
- The deviation in fund utilization remained within 10%, complying with regulatory and shareholder directives.
Key details
- IPO gross proceeds totaled Rs 7,700 million, with net proceeds of Rs 7,132.77 million after issue expenses of Rs 567.23 million.
- IPO proceeds were originally earmarked for borrowing repayment, hospital development, medical equipment purchase, inorganic acquisitions, and general corporate purposes.
- The company’s Auditor and Monitoring Agency verified fund utilization and compliance in line with shareholder approvals.
- No major changes were observed compared to earlier monitoring reports.
- The information was presented and approved by the Board of Directors and Audit Committee in their November 13, 2026 meetings.
Regulatory and governance context
- The Monitoring Agency Report was submitted pursuant to SEBI (Listing Obligations and Disclosure Requirements) and SEBI (Issue of Capital and Disclosure Requirements) Regulations.
- CRISIL Ratings Limited serves as the independent Monitoring Agency for the IPO proceeds.
- The report ensures transparency and compliance in the utilization of funds raised through the IPO.
- Stakeholders can access the report and disclosures on the company’s official website.
Highlights
- IPO gross proceeds of Rs 7,700 million with net proceeds of Rs 7,132.77 million after issue expenses.
- Rs 648.32 million reallocated from original IPO objects to capital expenditure on acquisition of The Medicity Hospital, Rudrapur.
- Use of proceeds and deviations are compliant with shareholder approvals.
- Monitoring Agency Report issued by CRISIL Ratings for quarter ended September 30, 2026.
- Deviation in utilization is within 10% range as per monitoring norms.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Sobhagya Mercantile Ltd. Sets Extraordinary General Meeting for December 11, 2026, via Video Conferencing
Sobhagya Mercantile Limited has issued a public notice convening an Extraordinary General Meeting (EGM) scheduled for December 11, 2026, at 11:30 A.M. IST. The meeting will be conducted through video conferencing and other audio-visual means, with e-voting facilities provided to shareholders.
Read Full StoryAPL Apollo Tubes Denies Promoter Stake Sale Rumors Following Speculative News
APL Apollo Tubes Limited issued a clarification on November 20, 2026, denying any knowledge or communication regarding a proposed sale of promoter family shares amid speculative media reports.
Read Full StoryIndusInd Bank Conducts November 2026 Investor and Analyst Meetings in Chennai with Leading Asset Managers
On November 19, 2026, IndusInd Bank Limited conducted analyst and institutional investor meetings in Chennai, involving prominent asset management companies such as Franklin Templeton, Bandhan AMC, Axis AMC, and Motilal Oswal AMC. The bank clarified no unpublished price sensitive information was shared during these discussions.
Read Full Story